AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways

Diabetic nephropathy (DN) is a major complication of diabetes. Currently, drugs are not available to effectively control the disease. Fluorofenidone (AKF-PD) is a recently developed drug; it possesses activities in reducing DN progression in preclinical research. Nonetheless, its renal protection an...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jiao, Peng, Zhangzhe, Yuan, QiongJing, Li, Qian, Peng, Yu, Wen, Rui, Hu, Zhaolan, Liu, Jun, Xia, Xiongfang, Deng, Hong, Xiong, Xuan, Hu, Jinyue, Tao, Lijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416244/
https://www.ncbi.nlm.nih.gov/pubmed/30867431
http://dx.doi.org/10.1038/s41598-018-36344-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416244/
https://www.ncbi.nlm.nih.gov/pubmed/30867431
http://dx.doi.org/10.1038/s41598-018-36344-w

Ejemplares similares